IL-12 Stimulation of Neonatal immunity
Download pdf
Abstract/Description: | The present invention relates to a method of inducing a Th1-like response against a pathogen in a neonatal host, which comprises administering to the neonatal host an effective amount of IL-12 and an antigen of the pathogen. Also encompassed by the present invention is a method of overcoming suppression of interferon-? (IFN-?) expression in a neonatal host due to exposure of the neonatal host to a pathogen or an antigen, which comprises administering to the neonatal host an effective amount of IL-12 and the antigen. The present invention also relates to a method of enhancing the cytokine expression against or in response to a pathogen in a neonatal host, which comprises administering to the neonatal host an effective amount of IL-12 and an antigen of the pathogen. |
---|---|
Subject(s): | 424/85.2 424/85.4 424/184.1 424/191.1 424/204.1 424/234.1 424/264.1 424/269.1 530/350 |
Date Issued: | 1999-11-16 |
Title: | IL-12 Stimulation of Neonatal immunity. |
|
---|---|---|
Name(s): |
Medical College of Ohio, assignee Metzger, Dennis W., inventor Arulanandam, Bernard P., inventor |
|
Type of Resource: | text | |
Genre: | patent | |
Publisher: | United States Patent and Trademark Office | |
Other Date: | Date Filed: 1998-03-05 | |
Date Issued: | 1999-11-16 | |
Physical Form: | application/pdf | |
Extent: | 18 p. | |
Abstract/Description: | The present invention relates to a method of inducing a Th1-like response against a pathogen in a neonatal host, which comprises administering to the neonatal host an effective amount of IL-12 and an antigen of the pathogen. Also encompassed by the present invention is a method of overcoming suppression of interferon-? (IFN-?) expression in a neonatal host due to exposure of the neonatal host to a pathogen or an antigen, which comprises administering to the neonatal host an effective amount of IL-12 and the antigen. The present invention also relates to a method of enhancing the cytokine expression against or in response to a pathogen in a neonatal host, which comprises administering to the neonatal host an effective amount of IL-12 and an antigen of the pathogen. | |
Identifier(s): |
utpatents-US5985264 (IID) Patent No.: US5985264 (patno) Appl. No.: 09/035593 (appno) |
|
Subject(s): |
424/85.2 424/85.4 424/184.1 424/191.1 424/204.1 424/234.1 424/264.1 424/269.1 530/350 |
|
Held by: | United States Patent and Trademark Office (USPTO) Public Search Facility | |
Location: | University of Toledo Digital Repository | |
Rights Statement: | No Copyright - United States | |
In Collections: |